Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403022 · ClinicalTrials.gov registry record · NA
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
A NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 9
- Study locations
NCT04403022: Active NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, sponsored by Intuitive Surgical.
NCT04403022 is a NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 60 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403022, a NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 9
- Study locations
Study Summary
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low anterior resections or right colectomy.
Primary Outcome
Performance defined as ability to complete the planned da Vinci SP-assisted colorectal procedure without conversion to an alternate approach.
Conditions Studied
Interventions
- DEVICE Robotic Assisted Surgery
Study Locations (9)
Florida
- Adventist Health System/Sunbelt - Orlando
Michigan
- Henry Ford - Detroit
Minnesota
- Mayo Clinic - Rochester
Nevada
- MountianView Hospital - Las Vegas
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Texas
- Houston Methodist Research Institute - Houston
Washington
- MultiCare - Tacoma - Tacoma
Dong-gu
- Ulsan University Hospital - Ulsan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
What the registry record for NCT04403022 still lists
NCT04403022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic Assisted Surgery is the first listed.
NCT04403022 lists 9 locations in 9 states (Florida, Michigan, Minnesota).
Frequently Asked Questions
What is clinical trial NCT04403022 about?
NCT04403022 is a clinical study titled "da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures". To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low anterior resections or right colectomy.
What is the current status of trial NCT04403022?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-03. Estimated completion is 2028-11-30.
What conditions does trial NCT04403022 study?
This clinical trial studies the following conditions: Colorectal Cancer, Benign or Malignant Rectal or Colon Tumors.
What interventions are being tested in trial NCT04403022?
The interventions under investigation include: Robotic Assisted Surgery (DEVICE).
Who is sponsoring clinical trial NCT04403022?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04403022 being conducted?
This trial has 9 study locations across Florida, Michigan, Minnesota, Nevada, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04403022's enrollment target sits among peer trials
60 258th of 381 higher than 121 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI